Vir Biotechnology, Inc.

Healthcare · Biotechnology · United States

Last price 11.75 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.99B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company’s preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting va...